74 related articles for article (PubMed ID: 10406683)
21. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I
J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
[TBL] [Abstract][Full Text] [Related]
22. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
[TBL] [Abstract][Full Text] [Related]
23. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Colombo A; Leon MB; Moses JW; Iversen P
Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of three polytetrafluoroethylene stent-grafts in a model of neointimal hyperplasia.
Dolmatch B; Dong YH; Heeter Z
J Vasc Interv Radiol; 2007 Apr; 18(4):527-34. PubMed ID: 17446544
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries.
Waksman R; Pakala R; Baffour R; Hellinga D; Seabron R; Tio FO; Wittchow E; Tittelbach M; Diener T; Harder C; Virmani R; Jones R
Cardiovasc Revasc Med; 2007; 8(4):259-74. PubMed ID: 18053948
[TBL] [Abstract][Full Text] [Related]
26. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
[TBL] [Abstract][Full Text] [Related]
27. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model.
Carter AJ; Aggarwal M; Kopia GA; Tio F; Tsao PS; Kolata R; Yeung AC; Llanos G; Dooley J; Falotico R
Cardiovasc Res; 2004 Sep; 63(4):617-24. PubMed ID: 15306217
[TBL] [Abstract][Full Text] [Related]
29. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model.
Prunotto M; Vignolini C; Lolli V; Black A; Gaggianesi S; Santarelli A; Galloni M
J Biomed Mater Res A; 2009 Mar; 88(4):872-9. PubMed ID: 18360883
[TBL] [Abstract][Full Text] [Related]
30. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation.
Takano M; Ohba T; Inami S; Seimiya K; Sakai S; Mizuno K
Eur Heart J; 2006 Sep; 27(18):2189-95. PubMed ID: 16893918
[TBL] [Abstract][Full Text] [Related]
31. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia.
Windecker S; Mayer I; De Pasquale G; Maier W; Dirsch O; De Groot P; Wu YP; Noll G; Leskosek B; Meier B; Hess OM;
Circulation; 2001 Aug; 104(8):928-33. PubMed ID: 11514381
[TBL] [Abstract][Full Text] [Related]
32. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
33. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model.
McKenna CJ; Burke SE; Opgenorth TJ; Padley RJ; Camrud LJ; Camrud AR; Johnson J; Carlson PJ; Lerman A; Holmes DR; Schwartz RS
Circulation; 1998 Jun; 97(25):2551-6. PubMed ID: 9657476
[TBL] [Abstract][Full Text] [Related]
34. New biocompatible polymer surface coating for stents results in a low neointimal response.
Bär FW; van der Veen FH; Benzina A; Habets J; Koole LH
J Biomed Mater Res; 2000 Oct; 52(1):193-8. PubMed ID: 10906692
[TBL] [Abstract][Full Text] [Related]
35. Granulomatous 'foreign body reactions' contribute to exaggerated in-stent restenosis.
Kornowski R; Hong MK; Virmani R; Jones R; Vodovotz Y; Leon MB
Coron Artery Dis; 1999; 10(1):9-14. PubMed ID: 10196682
[TBL] [Abstract][Full Text] [Related]
36. Use of polyetherurethane to improve the biocompatibility of vascular stents.
Fontaine AB; Dos Passos S; Spigos D; Cearlock J; Urbaneja A
J Endovasc Surg; 1995 Aug; 2(3):255-65. PubMed ID: 9234140
[TBL] [Abstract][Full Text] [Related]
37. Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model.
Kruse KR; Crowley JJ; Tanguay JF; Santos RM; Millare DS; Phillips HR; Zidar JP; Stack RS
Catheter Cardiovasc Interv; 1999 Apr; 46(4):503-7. PubMed ID: 10216025
[TBL] [Abstract][Full Text] [Related]
38. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries.
De Scheerder IK; Wilczek KL; Verbeken EV; Vandorpe J; Lan PN; Schacht E; De Geest H; Piessens J
Atherosclerosis; 1995 Apr; 114(1):105-14. PubMed ID: 7605369
[TBL] [Abstract][Full Text] [Related]
39. The response of fibrinogen, platelets, endothelial and smooth muscle cells to an electrochemically modified SS316LS surface: towards the enhanced biocompatibility of coronary stents.
Shahryari A; Azari F; Vali H; Omanovic S
Acta Biomater; 2010 Feb; 6(2):695-701. PubMed ID: 19607940
[TBL] [Abstract][Full Text] [Related]
40. Foreign body contamination during stent implantation.
Whelan DM; van Beusekom HM; van der Giessen WJ
Cathet Cardiovasc Diagn; 1997 Mar; 40(3):328-32. PubMed ID: 9062737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
